|
PSPH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68180000037488E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.764400E-04 |
| Normal-vs-Stage2 |
3.733900E-02 |
| Normal-vs-Stage3 |
6.318400E-02 |
| Normal-vs-Stage4 |
4.937800E-02 |
| Stage1-vs-Stage2 |
8.042800E-01 |
| Stage1-vs-Stage3 |
9.623600E-01 |
| Stage1-vs-Stage4 |
5.120400E-01 |
| Stage2-vs-Stage3 |
8.650200E-01 |
| Stage2-vs-Stage4 |
6.495600E-01 |
| Stage3-vs-Stage4 |
5.837600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14580000001963E-06 |
| Normal-vs-AfricanAmerican |
1.605000E-03 |
| Normal-vs-Asian |
4.063800E-01 |
| Caucasian-vs-AfricanAmerican |
9.066000E-01 |
| Caucasian-vs-Asian |
9.411000E-01 |
| AfricanAmerican-vs-Asian |
9.058600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54200000049387E-07 |
| Normal-vs-Female |
3.198300E-03 |
| Male-vs-Female |
5.605200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.082500E-02 |
| Normal-vs-Extreme_Weight |
2.402500E-03 |
| Normal-vs-Obese |
5.237200E-04 |
| Normal-vs-Extreme_Obese |
1.108250E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.114600E-01 |
| Normal_Weight-vs-Obese |
4.745200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.341000E-01 |
| Extreme_Weight-vs-Obese |
2.838800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.822200E-01 |
| Obese-vs-Extreme_Obese |
8.041400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.045800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.79080000051179E-07 |
| Normal-vs-Age(61-80Yrs) |
8.204500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.660400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.745400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.105200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.477600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.618500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.730000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.693800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73369996137041E-09 |
| Normal-VS-Type2 PRCC |
2.166200E-02 |
| Normal-VS-KIRP CIMP |
1.020560E-01 |
| Normal-VS-Unclassified PRCC |
5.532300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.508800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.706600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.570600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.306400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.799000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.155800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.115620E-02 |
| Normal-vs-N1 |
2.643700E-02 |
| Normal-vs-N2 |
1.362840E-01 |
| N0-vs-N1 |
7.351600E-01 |
| N0-vs-N2 |
8.193600E-01 |
| N1-vs-N2 |
6.914200E-01 |
|
|
